Drugs / Omicron Vaccine
last change Oct 2023 re-read 2 minutes ago

Omicron Vaccine

Vaccine

Developed for
COVID-19
Investigated by
Pontificia Universidad Catolica de Chile · Sinovac Life Sciences Co., Ltd.

Trials 1 · a red edge is where a trial was stopped

2023202420252026
PhaseRegistry idDatesIndicationSponsorStatusOutcome
Phase 2 NCT05593042 Nov 2022 → Oct 2023 COVID-19 Pontificia Universidad Catolica de Chile Completed No outcome recorded

Evidence & citations 2 cited values

Every value below carries the sentence it was read from. 1 source stands behind the page.

FieldValueCited text
Known as Omicron Vaccine ClinicalTrials.gov intervention name — accepted as the source's own label NCT05593042
Modality Vaccine “an inactivated Omicron variant vaccineNCT05593042